Safety of nonsteroidal antiinflammatory drugs in pregnant patients with rheumatic disease

Journal of Rheumatology

Volumn 23, Issue 6, 1996, Pages 1045-1049

  Østensen, Monika ^a   Østensen, Harald ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Department of Radiology   (Norway)

Author keywords

NEWBORN INFANT ADVERSE EFFECTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PREGNANCY

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; LABOR COMPLICATION; MENTAL DEVELOPMENT; PHYSICAL DEVELOPMENT; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RHEUMATIC DISEASE; TERATOGENESIS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FETUS; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RHEUMATIC DISEASES;

EID: 0029976665     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Østensen M, Husby G. Seronegative spondylarthritis and ankylosing spondylitis: Biological effects and management. In: Scott JS, Bird H, eds. Pregnancy, Autoimmunity and Connective Tissue Disorders. Oxford: Oxford University Press, 1990; 163-83.
2. Klipple GL, Cecere FA: Rheumatoid arthritis and pregnancy. Rheum Dis Clin North Am 1989;15:213-40.
3. Kilpatrick SJ, Russell KL: Characteristics of normal labor. Obstet Gynecol 1989;74:85-7.
4. Østensen M, Husby G: Ankylosing spondylitis and pregnancy. Rheum Dis Clin North Am 1989;15:241-54.
5. Østensen M:. Pregnancy in psoriatic arthritis. Scand J Rheumatol 1988;17:67-70.
6. Østensen M: Pregnancy in patients with a history of juvenile rheumatoid arthritis. Arthritis Rheum 1991;34:881-7.
7. Wilkinson AR, Aynsley-Green A, Mitchell MD: Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. Arch Dis Childh 1979;54:942-5.
8. Alun-Jones E, Williams J: Hyponatremia and fluid retention in a neonate associated with maternal naproxen overdosage. J Toxicol Clin Toxicol 1986;24:257-60.
9. Lewis RB, Schulman JD: Influence of acetylicsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973;2:1159-61.
10. Stuart MJ, Gross SJ, Elrad H, Graeber JE: Effects of acetylicsalicylic acid ingestion on maternal and neonatal hemostasis. N Engl J Med 1982;307:909-12.
11. van den Veyver IB, Moise KJ, Ou CN, Carpenter RJ: The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus. Obstet Gynecol 1993;82:500-3.
12. Moise KJ: Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am Obstel Gynecol 1993;168:1350-3.
13. Momma K, Takeuchi H: Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins 1983; 26:631-43.
14. Hennessy MD, Livingston EC, Papagianos J, et al: The incidence of ductal constriction and oligohydramnios during tocolytic therapy with ibuprofen (abstr). Am J Obstet Gynecol 1992;166:324.
15. Morales WJ, Madhav H: Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: A randomized study. Am J Obstes Gynecol 1993;169:97-102.
16. Wiggins DA, Elliott JP: Oligohydramnios in each sac of a triplet gestation caused by Motrin - fulfilling Kock's postulates. Am J Obstet Gynecol 1990;162:460-1.
17. Netter JC, Choulot JJ, dagues-Bie M, et al: Oligohydramnios and persistent neonatal pulmonary hypertension after use of ketoprofen during pregnancy. Semin Hop Paris 1990;66:1953-4.
18. Simeoni U, Messer J, Weisburd P, Haddad J, Willard D: Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors. Eur J Pediatr 1989;148:371-3.
19. Cantor B, Tyler T, Nelson RM, Stein GH: Oligohydramnios and transient neonatal anuria. A possible association with the maternal use of prostaglandin synthetase inhibitors. J Reprod Med 1980;24:220-3.
20. Østensen M: Optimisation of antirheumatic drug treatment in pregnancy. Clin Pharmacokinet 1994;27:486-503.
21. Garber JE: Long-term follow-up of children exposed in utero to antineoplastic agents. Semin Oncol 1989;16:437-44.
22. Herbst Al: Diethylstilbestrol exposure - 1984. N Engl J Med 1994;311:1433-4.
23. Parazzini F, Bortolus R, Chatenoud L, et al: Follow-up of children in the Italian study of aspirin in pregnancy (letter). Lancet 1 1994;343:1235.
24. Klebanoff MA, Berendes HW: Aspirin exposure during the first twenty weeks of gestation and IQ at four years of age. Teratology 1988;37:249-55.
25. Glascoe FP, Altemeier WA, MacLean WE: The importance of parents' concerns about their child's development. Am J Dis Child 1989;143:955-8.
26. Harris SR: Parents' and caregivers' perceptions of their childrens' development. Dev Med Child Neurol 1994;36:918-23.